Pharmacists have raised concerns about the significant threat to patient safety posed by shortages of essential medicines. A wide range of commonly used drugs, such as painkillers, antibiotics, blood pressure medications, and treatments for various conditions like epilepsy, pancreatic cancer, cystic fibrosis, diabetes, and ADHD, are currently in short supply. To address these shortages, Serious Shortage Protocols, which offer alternative prescriptions when medications are unavailable, are being implemented for several drugs, including Estradot, a hormone replacement therapy for menopausal symptoms.
Ashley Cohen, a pharmacist with over three decades of experience and a National Pharmacy Association Board Member, expressed alarm over the current unprecedented level of medicine shortages. Cohen emphasized that the situation has escalated beyond inconvenience to become a critical patient safety issue, particularly for individuals dependent on medications like those for epilepsy, where a lack of treatment could lead to severe consequences, including hospitalization or even death.
The shortage of medicines is attributed to soaring global prices, insufficient government funding, and supply disruptions caused by conflicts like the Iran war and the closure of the Strait of Hormuz, leading to delays in shipping and air-freight disruptions. The National Health Service (NHS) pays pharmacies a fixed rate for each dispensed medication, but the government’s list of price concessions, comprising medications that exceed the stipulated price, reached a record high with 210 drugs listed.
According to Mr. Cohen, global drug manufacturers prioritize selling medications to other countries like France and Germany due to higher payment offers, resulting in limited supplies reaching the UK. He highlighted the urgent need for increased government investment in the pharmaceutical market to address the issue effectively.
The scarcity of drugs has forced pharmacies to ration certain medications, such as Creon, critical for patients with pancreatic cancer and cystic fibrosis. The ongoing shortage of Creon has persisted for nearly two years, leading to challenges in ensuring consistent supply for patients, ultimately affecting their well-being. The risk of a potential black market emerging, where unreliable sources may exploit desperate patients by selling overpriced or ineffective drugs, is also a growing concern.
Individuals like Cathy Moreau, who travel abroad to obtain necessary medications like Creon due to local shortages, highlight the severity of the situation. The National Pharmacy Association’s survey revealed that 96% of pharmacies see the shortage as a significant threat to patient safety, with 83% reporting instances of patient frustration or anger due to unavailable medications.
Efforts are being made to address the crisis, with calls for the government to establish an emergency task force involving key stakeholders to tackle the shortages effectively. Additionally, there are appeals for legislative changes allowing pharmacists to make necessary prescription substitutions when essential drugs are not available, ensuring patients receive timely and appropriate treatment.